# Collection of bulk RNA data with drugs

<!--ts-->
* [Collection of bulk RNA data with drugs](#collection-of-bulk-rna-data-with-drugs)
   * [Drug treatment + bulk RNA profiling prior to treatment start](#drug-treatment--bulk-rna-profiling-prior-to-treatment-start)
      * [Example 1.](#example-1)
      * [Example 2.](#example-2)
   * [Drug treatment + bulk RNA profiling prior and after the treatment](#drug-treatment--bulk-rna-profiling-prior-and-after-the-treatment)
      * [Example 1.](#example-1-1)
      * [Example 2.](#example-2-1)

<!-- Created by https://github.com/ekalinin/github-markdown-toc -->
<!-- Added by: tyck, at: Thu Jun  6 13:37:36 EDT 2024 -->

<!--te-->

## Drug treatment + bulk RNA profiling prior to treatment start

### Garnett et al. Nature 2012.
This original study titled "Systematic identification of genomic markers of drug sensitivity in cancer cells," profiled 131 drugs across 639 human cell lines [Garnett et al Nature 2012](https://pubmed.ncbi.nlm.nih.gov/22460902/).

Other studies that re-use these data:

  * [Livnat Jerby-Arnon et al Cell 2018](https://pubmed.ncbi.nlm.nih.gov/30388455/) "A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade."



### Example 2.

## Drug treatment + bulk RNA profiling prior and after the treatment

### Example 1.

### Example 2.
